Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Levered Free Cash Flow (FCF)

Adverum Biotechnlgs Levered Free Cash Flow (FCF) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Levered Free Cash Flow (FCF) from 2014 to 2020.
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-11m a 19.21% decrease of -2m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-51m a 31.76% decrease of -16m year over year
  • Adverum Biotechnlgs Annual Levered Free Cash Flow (FCF) for 2019 was $-52m a 39.03% decrease of -20m from 2018
  • Adverum Biotechnlgs Annual Levered Free Cash Flow (FCF) for 2018 was $-32m a 19.23% decrease of -6m from 2017
  • Adverum Biotechnlgs Annual Levered Free Cash Flow (FCF) for 2017 was $-26m a 29.92% decrease of -8m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Levered Free Cash Flow (FCF) Data

06/2020$-11m
03/2020$-11m
12/2019$-22m
09/2019$-8m
06/2019$-9m
03/2019$-14m
12/2018$-8m
09/2018$-11m
06/2018$-5m
03/2018$-8m

Annual ADVM Levered Free Cash Flow (FCF) Data

2019$-52m
2018$-32m
2017$-26m
2016$-18m
2015$-17m
2014$-4m
2013$-1m